Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Dynamics' Q2 Revenues Rise 29 Percent

NEW YORK (GenomeWeb) – Cellular Dynamics International today reported that its second quarter revenues increased 29 percent year over year, but the firm missed Wall Street estimates on the top and bottom lines.

The Madison, Wis.-based provider of stem cells for research purposes reported total revenues of $3.6 million for the three months ended June 30, up from $2.8 million in the second quarter of 2013. Analysts, on average, had expected revenues of $4.9 million.

The company reported product sales of $2.4 million compared to $2 million for Q2 2013. Sales from collaborations, partnerships, and other revenues totaled $1.2 million, up from 843,000.

Cellular Dynamics posted a net loss of $8.6 million, or $.54 per share, for the quarter, falling short of the consensus Wall Street estimate of $.49 per share. For Q2 2013, the firm had reported a net loss of $5.1 million, or $2.92 per share. It used around 15.8 million shares to calculate its loss per share in Q2 2014 versus roughly 1.7 million shares in Q2 2013, before it became a publicly traded company in the summer of 2013.

Cellular Dynamics' R&D spending climbed 44 percent to $5.6 million from $3.9 million, while its SG&A expenses increased 73 percent to $5.7 million from $3.3 million.

The firm finished the quarter with $47.4 million in cash and cash equivalents.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.